Seeking to crack down on large biopharmaceutical M&A deals, FTC sues to block Illumina’s $ 8 billion acquisition – Endpoints News

by



[ad_1]

  1. Seeking to crack down on large biopharmaceutical mergers and acquisitions, FTC sues to block Illumina’s $ 8 billion acquisition of GrailEndpoints News
  2. FTC seeks to block Illumina’s $ 7.1 billion acquisition of Grail life sciences companyThe Wall Street Journal
  3. Illumina stock crashes as FTC moves to block $ 7.1 billion Grail acquisitionDaily Investor Business
  4. US wants to block Bezos-backed Grail Illumina dealBloomberg
  5. US files lawsuit to block Illumina’s acquisition of liquid biopsy groupFinancial Times
  6. View full coverage on Google News

[ad_2]

Source link